James Stanker
Equibles does not estimate personal net worth.
About James Stanker
Earlier roles on record: CFO at Processa Pharmaceuticals, Inc. (PCSA) until July 15, 2024. Processa Pharmaceuticals, Inc. reported in an 8-K filed July 17, 2024 that James Stanker retired as Chief Financial Officer. Processa Pharmaceuticals, Inc. reported in an 8-K filed July 17, 2024 that James Stanker resigned as Chief Financial Officer, effective July 15, 2024. The proxy statement of Processa Pharmaceuticals, Inc. reports total compensation of $342,624 for James Stanker in fiscal 2023, including a base salary of $160,200. Disclosed compensation is on record for 5 fiscal years. James Stanker has spoken on 2 earnings calls across 1 company, most recently for Processa Pharmaceuticals, Inc. on August 12, 2022. The companies whose calls James Stanker spoke on are classified in the Healthcare sector.
“Mr. Skibsted succeeds James Stanker, who is retiring and staying on in an advisory role to assist in the transition.”
“On July 15, 2024, by mutual agreement, James Stanker resigned as Chief Financial Officer of the Company, effective July 15, 2024.”
James Stanker on recent calls
“Thank you, and welcome to Processa’s second quarter 2022 results and clinical pipeline update conference call. Joining me on the call today are our Chief Executive Officer, Dr. David Young; and our Chief Operating Officer, Mike Floyd.”
“Thank you and welcome to Processa's second quarter 2021 quarterly results and drug development update conference call. Joining me on the call today are our Chief Executive Officer, Dr. David Young; and our Chief Operating Officer, Mike Floyd.”
Affiliation history
-
Start not stated–2024-07-15
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $160,200 | $342,624 |
| 2022 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $93,875 | $1,040,278 |
| 2021 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $434,512 |
| 2020 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $467,552 |
| 2019 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | $87,500 | $250,702 |